| Sustained release talazoparib implants for localized treatment of BRCA1-deficient breast cancer JE Belz, R Kumar, P Baldwin, NC Ojo, AS Leal, DB Royce, D Zhang, ... Theranostics 7 (17), 4340, 2017 | 30 | 2017 |
| Radiosensitizing silica nanoparticles encapsulating docetaxel for treatment of prostate cancer J Belz, N Castilla-Ojo, S Sridhar, R Kumar Cancer Nanotechnology: Methods and Protocols, 403-409, 2017 | 13 | 2017 |
| Abstract B30: sustained release of PARP inhibitor talazoparib and chemotherapeutic docetaxel from modified brachytherapy spacers for treatment of breast and prostate cancer J Belz, NC Ojo, P Baldwin, R Kumar, A Ven, K Liby, R Cormack, ... Cancer Research 77 (2_Supplement), B30-B30, 2017 | 1 | 2017 |
| Sustained release of PARP inhibitor Talazoparib and chemotherapeutics from biodegradable implants for treatment of breast and prostate cancer J Belz, N Castilla Ojo, P Baldwin, R Kumar, A van de Ven, K Liby, ... Cancer Research 76 (14_Supplement), 3900-3900, 2016 | 1 | 2016 |
| Abstract B29: Nanoformulations and sustained delivery systems for the PARP inhibitors Olaparib and Talazoparib P Baldwin, A Ohman, J Belz, J Thong, NC Ojo, K Liby, D Dinulescu, ... Cancer Research 77 (2_Supplement), B29-B29, 2017 | | 2017 |
| Sustained release of PARP inhibitor Talazoparib and chemotherapeutic Docetaxel from modified brachytherapy spacers for treatment of breast and prostate cancer J Belz, NC Ojo, P Baldwin, R Kumar, A van de Ven, K Liby, R Cormack, ... CANCER RESEARCH 77, 2017 | | 2017 |
| Docetaxel-Loaded Brachytherapy Spacers for Combined Chemoradiation Therapy in Prostate Cancer J Belz, NC Ojo, R Kumar, RA Cormack, M Makrigiorgos, S Sridhar, ... International Journal of Radiation Oncology, Biology, Physics 96 (2), S109, 2016 | | 2016 |
